Screener
United Therapeutics UTHR Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general, and administrative | 206.7 | 212.5 | 390.8 | 382.6 |
| Total operating expenses | 452.5 | 434.1 | 908.2 | 845.7 |
| Operating income | 330.8 | 364.5 | 656.6 | 747.3 |
| Interest income | 31.5 | 51.3 | 73.3 | 102.4 |
| Interest expense | (2.9) | (7.3) | (5.9) | (13.4) |
| Other income (expense), net | 13.3 | (0.1) | (33.0) | (4.4) |
| Total other income, net | 41.9 | 43.9 | 34.4 | 84.6 |
| Income before income taxes | 372.7 | 408.4 | 691.0 | 831.9 |
Item 1. Consolidated Financial Statements
FAQ
- What is United Therapeutics's interest income?
- United Therapeutics (UTHR) reported interest income of $31.5M in Q2 2026.
- How has United Therapeutics's interest income changed year-over-year?
- United Therapeutics's interest income decreased by 38.6% year-over-year, from $51.3M to $31.5M.
- What is the long-term trend for United Therapeutics's interest income?
- Over 4 years (2021 to 2025), United Therapeutics's interest income has grown at a 84.1% compound annual growth rate (CAGR), from $16.7M to $192M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about United Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude